Integrated Filing — IndAS



General information about company
Scrip Code 532372
NSE Symbol VIRINCHI
MSEI Symbol NOTLISTED
ISIN INE539B01017
Name of company VIRINCHI LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 13-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 28-May-2025   20:00:00
End date and time of board meeting 28-May-2025   23:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-05-03
Indicate Company website link for updated RPT policy of the Company https://www.virinchi.com/pdf/policyOfRelatedPartyTransaction.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Disclosure for the default on loans and debt securities is not applicable for the current quarter



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 367806000 1394756000
Other income 13584000 139377000
Total income 381390000 1534133000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 161281000 542734000
(e) Finance costs 44604000 142792000
(f) Depreciation, depletion and amortisation expense 26514000 111383000
(f) Other Expenses
1 administrative and other expenditure 120267000 536734000
Total other expenses 120267000 536734000
Total expenses 352666000 1333643000
3 Total profit before exceptional items and tax 28724000 200490000
4 Exceptional items 0 0
5 Total profit before tax 28724000 200490000
6 Tax expense
7 Current tax 5800000 49961000
8 Deferred tax 5839000 -9861000
9 Total tax expenses 11639000 40100000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 17085000 160390000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 17085000 160390000
17 Other comprehensive income net of taxes 0 0
18 Total Comprehensive Income for the period 17085000 160390000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1026469000 1026469000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 3248406000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.16 1.59
Diluted earnings (loss) per share from continuing operations 0.17 1.59
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.16 1.59
Diluted earnings (loss) per share from continuing and discontinued operations 0.17 1.59
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1095989000
Capital work-in-progress 124363000
Investment property
Goodwill 0
Other intangible assets 850183000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 672849000
Trade receivables, non-current
Loans, non-current 2879072000
Other non-current financial assets
Total non-current financial assets 3551921000
Deferred tax assets (net)
Other non-current assets 5748000
Total non-current assets 5628204000
2 Current assets
Inventories 0
Current financial asset
Current investments 0
Trade receivables, current 317867000
Cash and cash equivalents 48492000
Bank balance other than cash and cash equivalents 0
Loans, current 110192000
Other current financial assets
Total current financial assets 476551000
Current tax assets (net)
Other current assets 145849000
Total current assets 622400000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 6250604000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1026469000
Other equity 3248406000
Total equity attributable to owners of parent 4274875000
Non controlling interest
Total equity 4274875000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1006843000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 1006843000
Provisions, non-current 37591000
Deferred tax liabilities (net) -5166000
Deferred government grants, Non-current
Other non-current liabilities 290158000
Total non-current liabilities 1329426000
Current liabilities
Current financial liabilities
Borrowings, current 344377000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 25644000
Total Trade payable 25644000
Other current financial liabilities
Total current financial liabilities 370021000
Other current liabilities
Provisions, current 276282000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 646303000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1975729000
Total equity and liabilites 6250604000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 SAAS business 346332000 1333732000
2 IT enabled services 21474000 61025000
Total Segment Revenue 367806000 1394757000
Less: Inter segment revenue
Revenue from operations 367806000 1394757000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 SAAS business 58208000 198412000
2 IT enabled services 1537000 5492000
Total Profit before tax 59745000 203904000
i. Finance cost 44604000 44604000
ii. Other Unallocable Expenditure net off Unallocable income -13583000 -13583000
Profit before tax 28724000 200490000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 SAAS business 0 0
2 IT enabled services 0 0
Total Segment Asset 0 0
Un-allocable Assets 0 0
Net Segment Asset 0 0
4 Segment Liabilities
Segment Liabilities
1 SAAS business 0 0
2 IT enabled services 0 0
Total Segment Liabilities 0 0
Un-allocable Liabilities 0 0
Net Segment Liabilities 0 0
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 200490000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 142792000
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables, current -521509000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -312891000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 109021000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 2363000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -580224000
Net cash flows from (used in) operations -379734000
Dividends received 0
Interest paid 61465000
Interest received 0
Income taxes paid (refund) 49961000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -491160000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment -73868000
Purchase of property, plant and equipment 0
Proceeds from sales of investment property 0
Purchase of investment property -2694000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities -71174000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 328081000
Proceeds from issuing other equity instruments -73500000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 332394000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 0
Interest paid 81327000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 505648000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -56686000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -56686000
Cash and cash equivalents cash flow statement at beginning of period 105178000
Cash and cash equivalents cash flow statement at end of period 48492000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 P MURALI & CO Yes 30-Nov-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 VIRINCHI LIMITED M V Srinivasa Rao Key management personnel of entity or parent Remuneration - 2881000 0 0
2 VIRINCHI LIMITED VEDULA SATYANARAYANA Key management personnel of entity or parent Remuneration - 3581000 0 0
3 VIRINCHI LIMITED KOLLI RAVINDRANATH TAGORE Key management personnel of entity or parent Remuneration - 1781000 0 0
4 VIRINCHI LIMITED VISWANATH KOMPELLA Promoter Remuneration - 16501000 0 0
5 VIRINCHI LIMITED KSOFT SYSTEMS INC Subsidiaries Loan - 27317000 240382000 213065000
6 VIRINCHI LIMITED TENSOR FIELDS CONSULTANCY SERVICES PRIVATE LIMITED Subsidiaries Interest received - 590000 36358000 30189000
7 VIRINCHI LIMITED ASCLEPIUS CONSULTING &TECHNOLOGIES PRIVATE LIMTIED Subsidiaries Interest received - 2428000 71747000 73932000
8 VIRINCHI LIMITED VIRINCHI HEALTH CARE PRIVATE LIMITED Subsidiaries Interest received - 45155000 1900360000 2042274000
9 VIRINCHI LIMITED VIRINCHI MEDIA & ENTERTAINMENT PRIVATE LIMITED Subsidiaries Interest received - 810000 22870000 24179000
10 VIRINCHI LIMITED TYOHAR FOODS PRIVATE LIMITED Subsidiaries Interest received - 449000 13267000 13670000
11 VIRINCHI LIMITED VIRINCHI LEARNING PRIVATE LIMITED Subsidiaries Interest received - 670000 18679000 21450000
12 VIRINCHI LIMITED V23 MEDICAL SOLUTIONS PRIVATE LIMITED Subsidiaries Interest received - 22000 637000 657000
13 VIRINCHI LIMITED VIRINCHI COMBINATORICS & SYSTEMS BIOLOGY PRIVATE LIMITED Subsidiaries Interest received - 35000 1033000 1064000
14 VIRINCHI LIMITED QFUND TECHNOLOGIES PRIVATE LIMITED Subsidiaries Interest received - 1773000 61756000 63352000
15 VIRINCHI LIMITED VIVO BIO TECH LIMITED Common Promoter Loan - 111496000 113780000 2284000
16 VIRINCHI LIMITED VIVO BIO TECH LIMITED Common Promoter Interest paid - 1207000 0 1207000
17 VIRINCHI LIMITED VIVO BIO TECH LIMITED Common Promoter Any other transaction LOAN - ICD - 80000000 0 80000000
18 VIRINCHI LIMITED PKI SOLUTIONS PRIVATE LIMITED Common Promoter Advance - 31301000 2069000 -29232000
19 VIRINCHI LIMITED GAJWEL DEVELOPERS PRIVATE LIMITED Common Promoter Loan - 15000000 0 15000000
20 VIRINCHI HEALTHCARE PRIVATE LIMITED GAJWEL DEVELOPERS PRIVATE LIMITED Common Promoter Advance - 441000 1013000 1454000
21 VIRINCHI HEALTHCARE PRIVATE LIMITED SHRI SHRI RESORTS PRIVATE LIMITED Common Promoter Advance - 443000 44482000 44925000
22 VIRINCHI HEALTHCARE PRIVATE LIMITED PKI SOLUTIONS PRIVATE LIMITED Common Promoter Loan - -23741000 32405000 8664000
23 VIRINCHI HEALTHCARE PRIVATE LIMITED BHARAT MEGAWATTS GEN PRIVATE LIMITED Common Promoter Loan - -460000 534000 74000
24 VIRINCHI HEALTHCARE PRIVATE LIMITED VIRA SYSTEMS PRIVATE LIMITED Common Promoter Advance - 51000 2099000 2150000
25 VIRINCHI HEALTHCARE PRIVATE LIMITED MAXCELL PHONE COMMUNICATIONS PRIVATE LIMITED Common Promoter Advance - 527000 1937000 2464000
26 VIRINCHI HEALTHCARE PRIVATE LIMITED IRON AGE INDIA PRIVATE LIMITED Common Promoter Advance - 342000 2143000 2485000
27 VIRINCHI HEALTHCARE PRIVATE LIMITED VIVO CONSULTING SERVICES PRIVATE LIMITED Common Promoter Advance - -2003000 2046000 43000
28 VIRINCHI HEALTHCARE PRIVATE LIMITED VIVO BIO DISCOVERY SERVICES PRIVATE LIMITED Common Promoter Advance - -2053000 2041000 -12000
29 VIRINCHI HEALTHCARE PRIVATE LIMITED VIVO BIO LABS PRIVATE LIMITED Common Promoter Advance - -1972000 1992000 20000
30 VIRINCHI HEALTHCARE PRIVATE LIMITED VIVO BIO DEVELOPERS INDIA PRIVATE LIMITED Common Promoter Advance - -1637000 1980000 343000
31 VIRINCHI HEALTHCARE PRIVATE LIMITED VIVO BIO TECH LIMITED Common Promoter Loan - -37299000 38017000 718000
32 VIRINCHI HEALTHCARE PRIVATE LIMITED TYOHAR FOODS PRIVATE LIMITED Common Promoter Purchase of goods or services - 1074000 0 0
33 VIRINCHI HEALTHCARE PRIVATE LIMITED VIRINCHI COMBINATORICS & SYSTEMS BIOLOGY PRIVATE LIMITED Common Promoter Purchase of goods or services - 850000 0 0
34 VIRINCHI HEALTHCARE PRIVATE LIMITED VIRINCHI MEDIA & ENTERTAINMENT PRIVATE LIMITED Common Promoter Purchase of goods or services - 439000 0 0
35 VIRINCHI HEALTHCARE PRIVATE LIMITED V23 MEDICAL SOLUTIONS PRIVATE LIMITED Common Promoter Purchase of goods or services - 1486000 0 0
Total value of transaction during the reporting period 279485000